RenalytixAI
In Brief This Week: QuidelOrtho, Revvity, CeGaT, Mindera Health, Fluxergy, NeuroKaire, More
News items for the week of Nov. 18, 2024.
Renalytix Partners With Danish Diabetes Center on Kidney Disease Test Rollout
Renalytix received clearance for the test from the US Food and Drug Administration about a year ago and is now preparing for commercialization in other markets.
Earnings Roundup: Renalytix, DermTech, Oncocyte, Aspira Women's Health, Exagen, More
Renalytix, DermTech, Oncocyte, Aspira Women's Health, and others reported their first quarter earnings this week.
Top Five Articles on 360Dx Last Week: QuidelOrtho's Plans; Sekisui's EUAs for COVID Tests; More
Last week, readers were most interested in an update by QuidelOrtho management on the direction of the firm.
Renalytix Stock Soars on Disclosure of Potential Acquisition
The company said it has been approached by a large diagnostics firm regarding a potential acquisition and that it has launched a formal sales process.
Jun 30, 2023
Renalytix Kidney Disease Test Gets FDA Clearance
Oct 31, 2022
Renalytix Posts $2.9M in Revenue for Fiscal 2022
Jul 1, 2022
360Dx Top 30 Drops 5 Percent in June
Dec 7, 2021
Renalytix Posts $482K in Fiscal Q1 Revenues
Oct 21, 2021